InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: None

Tuesday, 06/08/2021 4:07:50 PM

Tuesday, June 08, 2021 4:07:50 PM

Post# of 140474
It becomes immediately obvious where someone stands on Titan Medical and what their objectives are when they repeatedly refer to the MDT licensing agreement as 1/3 of their IP, instead of acknowledging the following:

The IP includes patents which were approved over the past year. All of them. More than the 4 or 5 total from "the competition" which so far were all software (so much for having a robot).

The IP includes patent applications, which get a date stamp when filed and are then officially part of the IP.

By continually referring to "1/3 of their IP", they are implying, probably intentionally, that there is some value assigned to the 55-ish patents which currently constitute 1/3 of Titan's IP. What was really licensed was approximately 1/3 of the IP which was in the form of approved patents at the time of the agreement from over a year ago. This NOW represents well under 10% of Titan's IP.

So moving forward, anyone addressing Titan's IP being licensed should be sure to reference it accurately, e.g. "Medtronic has licensed around 8% of Titan's IP." Much more correct this way.